Besides, the microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) colon cancers have high PD-L1 expression, and treatment with a PD-L1 antibody is highly effective with low systemic toxicity (Shen et al. 2019). This evidence concerns the gene CD274 and malignant colon neoplasm.